These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7191292)

  • 1. Antispasmodic activity of rociverine on the smooth musculature of the urinary tract. Comparative in vitro study.
    Schiantarelli P; Murmann W
    Arzneimittelforschung; 1980; 30(7):1102-9. PubMed ID: 7191292
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of rociverine on the human ureter: in vivo and in vitro experimental study.
    Potenzoni D; Zappia L; Sacchini P; Bezzi E
    Pharmacol Res Commun; 1984 Aug; 16(8):765-74. PubMed ID: 6494219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of smooth muscle relaxation by rociverine.
    D'Agostino G; Zonta F; Santagostino Barbone MG; Grana E; Brunori P; Subissi A
    Arzneimittelforschung; 1984; 34(5):584-9. PubMed ID: 6540576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further observations on the antispasmodic activity of rociverine.
    Coruzzi G; Adami M; Poli E; Bertaccini G
    Farmaco Prat; 1982 Apr; 37(4):109-15. PubMed ID: 7084440
    [No Abstract]   [Full Text] [Related]  

  • 5. Rociverine citrate: a new spasmolytic agent, potentially useful in the treatment of urinary bladder hyperreflexia.
    Subissi A; Maggi CA; Meli A
    Jpn J Pharmacol; 1986 Oct; 42(2):153-7. PubMed ID: 3540391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions.
    Schiantarelli P; Murmann W; Magi S
    Arzneimittelforschung; 1979; 29(5):760-5. PubMed ID: 582975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity.
    Toson G; Schiantarelli P; Murmann W
    Arzneimittelforschung; 1978; 28(7):1130-42. PubMed ID: 582702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystometric evaluation of the activity of a new spasmolytic agent - rociverine.
    Manganelli A
    Farmaco Prat; 1979 Sep; 34(9):384-92. PubMed ID: 553816
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism of calcium-induced contraction in potassium-depolarized rabbit detrusor muscle strips by dicyclomine hydrochloride and rociverine.
    Downie JW; McGuire RP
    Can J Physiol Pharmacol; 1981 Aug; 59(8):853-6. PubMed ID: 7296384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of flavoxate antispasmodic activity comparative in vitro studies.
    Cazzulani P; Panzarasa R; De Stefani C; Graziani G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):189-200. PubMed ID: 4026456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rociverine compared with other spasmolytics for cardiovascular effects.
    Guelfi M; Schiantarelli P; Subissi A
    Farmaco Prat; 1981 Aug; 36(8):374-82. PubMed ID: 7274417
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of a new spasmolytic agent, rociverine, on intraocular pressure, pupil size and iridocorneal angle in patients with angle-closure glaucoma.
    Pardini M; Saponati G
    Pharmatherapeutica; 1983; 3(7):445-50. PubMed ID: 6669589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sintropium bromide (VAL 480): a new spasmolytic agent in general surgery].
    Bianchi M; Casetti M; Pulvirenti A; Biraghi M
    Minerva Chir; 1986 Oct; 41(19):1661-4. PubMed ID: 3808371
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro study of antispasmodic effects of dicyclomine hydrochloride on vesicourethral smooth muscle of guinea pig and rabbit.
    Khanna OP; DiGregorio GJ; Barbieri EJ; McMichael R; Ruch E
    Urology; 1979 Apr; 13(4):457-62. PubMed ID: 433063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rociverine and other spasmolytic agents on caerulein-induced delay in gastric emptying in the conscious rat.
    Subissi A; Guelfi M
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):130-7. PubMed ID: 7114969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressant action of oxybutynin on the contractility of intestinal and urinary tract smooth muscle.
    Tonini M; Rizzi CA; Perucca E; De Ponti F; D'Angelo L; Del Vecchio A; Crema A
    J Pharm Pharmacol; 1987 Feb; 39(2):103-7. PubMed ID: 2881993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic activity of 2-azabicyclo(2.2.2)octane analogs of acetylcholine.
    Borne RF; Clark CR; Waters IW
    J Pharm Sci; 1974 Oct; 63(10):1559-62. PubMed ID: 4436789
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on prostaglandins. III. Synthesis of bicyclo[4.3.0]nonane derivatives.
    Inukai N; Iwamoto H; Tamura T; Yanagisawa I; Ishii Y; Takagi T; Tomioka K; Murakami M
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1414-7. PubMed ID: 1021296
    [No Abstract]   [Full Text] [Related]  

  • 19. Antispasmodic activity of rociverine. Manometric findings and controlled clinical trial.
    Lanfranchi GA; Marzio L; Campieri M; Brignola C; Trento L
    Panminerva Med; 1980 Jan-Mar 22; 22(1):7-12. PubMed ID: 6997806
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of a new antispasmodic drug, rociverine, in dynamic dystocia].
    Pardini I; Maresi MP
    Minerva Ginecol; 1980 Sep; 32(9):831-6. PubMed ID: 7219836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.